We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SJR
126
DELISTED
Shaw Communications Inc.
SJR
$11.7M 0.23%
565,456
+331,410
+142% +$6.96M
RF icon
127
Regions Financial
RF
$26.3B
$11.6M 0.23%
800,524
-68,412
-8% -$1.01M
FITB
128
Fifth Third Bancorp
FITB
$52B
$11.6M 0.23%
457,566
-4,971
-1% -$133K
CPRT icon
129
Copart
CPRT
$25.9B
$11.6M 0.22%
+1,499,296
New +$11M
OMC icon
130
Omnicom Group
OMC
$22.7B
$11.5M 0.22%
133,408
+104,717
+365% +$8.93M
AAL icon
131
American Airlines Group
AAL
$9.58B
$11.3M 0.22%
266,009
+91,755
+53% +$4.15M
PSX icon
132
Phillips 66
PSX
$82.9B
$11.2M 0.22%
141,328
+17,409
+14% +$1.4M
KMB icon
133
Kimberly-Clark
KMB
$36.4B
$11M 0.21%
83,428
+56,521
+210% +$7.13M
GT icon
134
Goodyear
GT
$2.07B
$11M 0.21%
305,026
-166,281
-35% -$5.65M
ENTA icon
135
Enanta Pharmaceuticals
ENTA
$372M
$11M 0.21%
356,000
+120,000
+51% +$3.74M
WB icon
136
Weibo
WB
$1.9B
$10.9M 0.21%
209,000
+144,500
+224% +$7.19M
PH icon
137
Parker-Hannifin
PH
$125B
$10.8M 0.21%
67,305
+52,953
+369% +$8.04M
NBIX icon
138
Neurocrine Biosciences
NBIX
$17.7B
$10.7M 0.21%
247,000
+78,000
+46% +$3.34M
EMR icon
139
Emerson Electric
EMR
$82.9B
$10.7M 0.21%
178,533
+91,044
+104% +$5.44M
SCI icon
140
Service Corp International
SCI
$11.4B
$10.6M 0.2%
342,000
+131,846
+63% +$3.97M
VIAB
141
DELISTED
Viacom Inc. Class B
VIAB
$10.3M 0.2%
219,855
+29,219
+15% +$1.23M
PYPL icon
142
PayPal
PYPL
$49.5B
$10.2M 0.2%
236,482
+63,394
+37% +$2.65M
USB icon
143
US Bancorp
USB
$99.6B
$10.1M 0.2%
196,546
+65,423
+50% +$3.49M
LUV icon
144
Southwest Airlines
LUV
$22.1B
$10.1M 0.19%
187,008
+17,973
+11% +$967K
K
145
DELISTED
Kellanova
K
$9.82M 0.19%
144,019
+120,448
+511% +$8.31M
BHI
146
DELISTED
Baker Hughes
BHI
$9.8M 0.19%
163,839
+12,406
+8% +$755K
KYNB
147
Kyntra Bio
KYNB
$28.5M
$9.71M 0.19%
15,760
-2,640
-14% -$1.61M
BAC icon
148
Bank of America
BAC
$435B
$9.69M 0.19%
410,557
+67,748
+20% +$1.61M
SBUX icon
149
Starbucks
SBUX
$118B
$9.66M 0.19%
165,379
+43,736
+36% +$2.47M
MA icon
150
Mastercard
MA
$477B
$9.56M 0.19%
85,039
-5,259
-6% -$576K
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.